Literature DB >> 2596931

Organ procurement for pulmonary transplantation.

M Zenati1, R D Dowling, J M Armitage, R L Kormos, J S Dummer, R L Hardesty, B P Griffith.   

Abstract

Selection of suitable donors is critical to the success of clinical pulmonary transplantation. Requirements for lung donors, management before explantation, and methods of preservation were reviewed for the 70 heart-lung, eight double-lung, and two single-lung transplantations performed at the University of Pittsburgh since 1982. Careful observation of trends of hyperoxygenation studies, chest roentgenograms, and Gram stain and culture results of tracheal secretions, as well as findings on bronchoscopy, can help identify which lungs not only have adequate function but are acceptable for transplantation. In spite of the rigid criteria used, 76% of tracheal cultures from donors deemed acceptable grew organisms. The presence of oropharyngeal flora has been shown to correlate with the development of early intrathoracic infections in the recipient. Prophylactic broad-spectrum antibiotic treatment of the donor is desirable to treat microbial contamination that could cause focal injury to the donor lung and predispose to infection in the recipient. Acceptance of less than ideal donors is ill-advised even though rejection of such donors conflicts with the current shortage of organs.

Entities:  

Mesh:

Year:  1989        PMID: 2596931     DOI: 10.1016/0003-4975(89)90696-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  [The concept of lung and heart-lung preservation within the scope of multiple organ procurement].

Authors:  H R Zerkowski; N Doetsch; A Hellinger; J C Reidemeister
Journal:  Langenbecks Arch Chir       Date:  1991

2.  Successful transplantation of marginally acceptable thoracic organs.

Authors:  I L Kron; C G Tribble; J A Kern; T M Daniel; C E Rose; J D Truwit; L H Blackbourne; J D Bergin
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

3.  Pediatric lung transplantation. The years 1985 to 1992 and the clinical trial of FK 506.

Authors:  J M Armitage; F J Fricker; G Kurland; R L Hardesty; M Michaels; S Morita; T E Starzl; S A Yousem; R Jaffe; B P Griffith
Journal:  J Thorac Cardiovasc Surg       Date:  1993-02       Impact factor: 5.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.